Cancer drug screen based on cell cycle uncoupling

Details Cancer drug screen based on cell cycle uncoupling Cancer drug screen based on cell cycle uncoupling

1996-03-22

1999-04-27

Ketter, James

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

B24B 1900, C12N 510

Patent

active

058979999

ABSTRACT:
Checkpoint gene-defective human cells are useful for screening potential anti-tumor agents. Potential therapeutic agents are screened for the ability to cause DNA accumulation or cell death in a checkpoint gene-defective human cell.

REFERENCES:
patent: 5225326 (1993-07-01), Bresser et al.
patent: 5569824 (1996-10-01), Donehower et al.
patent: 5583034 (1996-12-01), Green et al.
patent: 5612018 (1997-03-01), Bonyhadi et al.
patent: 5622836 (1997-04-01), Walker et al.
Gorczyca, "Detection of DNA Strand Breaks in Individual Apoptotic Cells by the in Situ Terminal Deoxynucleotidyl Transferase and Nick Translation Assays," Cancer Research, 53:1945-1951 (1993).
Crissman, H.A. et al. "Normal and Perturbed Chinese Hamster Ovary Cells: Correlation of DNA, RNA and Protein Content by Flow Cytometry." The Journal of Cell Biology. Jul. 1985, vol. 101, pp. 141-147.
Oberhammer, F. et al. "Induction of apoptosis in cultured hepatocytes and in the regressing liver by transforming growth factor-.beta.1 occurs without activation of an endonuclease". Toxicology Letters. Dec. 1992, vol. 64/65, pp. 701-704.
Kung et al. PNAS. vol. 87, pp. 9553-9557, Dec. 1990.
Hunter et al. Cell. vol. 79, pp. 573-582, Nov. 1994.
Little et al. The Journal of Biol. Chem. vol. 270, No. 19, pp. 11033-11036, May 1995.
Girinsky et al. Cancer Research. vol. 55, pp. 3726-3731. Nov. 1995.
Vidal et al. Melanoma Research. vol. 5, pp. 243-250, Aug. 1995.
Waldman et al. Cancer Research. vol. 55, pp. 5187-5190, Nov. 15, 1995.
Takahashi, T. et al. Science vol. 246: 491-494 1989.
Diller et al. Mol. Cell. Biol. 1990 vol. 10(11):5772-5781.
Brugarolos et al. Nature 1995 vol. 377:552-557.
Brugarolas, "Radiation-induced Cell Cycle Arrest Compromised By p21 Deficiency," Nature, 377:552-557 (1995).
Deng, "Mice Lacking p21.sup.CIP1/WAF1 Undergo Normal Development, But Are Defective in G1 Checkpoint Control," Cell, 82:675-684 (1959).
Gao, "Somatic Mutations of the WAF1/CIP1 Gene in Primary Prostrate Cancer," Oncogene, 11, 1395-1398 (1995).
Hotz, Changes in Nuclear Chromatin Related in Apoptosis or Necrosis Induced by the DNA Topoisomerase II Inhibitor Fostriecin in MOLT-4 and HL-60 Cells Are Revealed by Altered DNA Sensitivity to Denaturation, Exp. Cell Research, 201:184-191 (1992).
Hunter, "Cyclins and Cancer II: Cyclin D and CDK Inhibitors Come of Age, Cell, 79:573-582 (1994).
Kung, "Cell Line-Specific Differences in the Control of Cell Cycle Progression in the Absence of Mitosis," Cell Biology, 87:9553-9557.
Sherr, "Inhibitors of Mammalian G.sub.1 Cyclin-Dependent Kinasec," Genes & Development, 9:1149-1163 (1995).
Swat, "Detection of Apoptosis of Immature CD4.sup.+ 8.sup.+ Thymocytes by Flow Cytometry," J. Immunol. Meth. 137:79-87 (1991).
Woods, "Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway," Molecular Medicine, 1:506-526 (1995).

Affiliated with

Also associated with

Rating

Cancer drug screen based on cell cycle uncoupling does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cancer drug screen based on cell cycle uncoupling, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer drug screen based on cell cycle uncoupling will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-685545